Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry

Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry

Abstract The differentiation between a pulmonary metastasis and a newly developed squamous cell carcinoma of the lung in patients with prior head and neck squamous cell carcinoma (HNSCC) is difficult due to a lack of biomarkers but is crucially important for the prognosis and therapy of the affected...

Full description

Bibliographic Details
Main Authors: Annika Richter, Alexander Fichtner, Jasmin Joost, Philipp Brockmeyer, Philipp Kauffmann, Henning Schliephake, Alexander Hammerstein‐Equord, Stefan Kueffer, Henning Urlaub, Thomas Oellerich, Philipp Ströbel, Hanibal Bohnenberger, Felix Bremmer
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:The Journal of Pathology: Clinical Research
Subjects:
SILAC‐mass spectrometry
squamous cell carcinoma
head and neck
lung
metastasis
cell culture
Online Access:https://doi.org/10.1002/cjp2.244

Internet

https://doi.org/10.1002/cjp2.244

Similar Items